The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B.
作者信息
Mao Xianhua, Mak Lung Yi, Seto Wai-Kay
机构信息
Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.
State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
出版信息
Clin Mol Hepatol. 2023 Jul;29(3):690-692. doi: 10.3350/cmh.2023.0173. Epub 2023 May 30.
Abstract
摘要
相似文献
1
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B.关于脂肪肝对慢性乙型肝炎患者肝脏相关结局及死亡率影响的最新证据。
Clin Mol Hepatol. 2023 Jul;29(3):690-692. doi: 10.3350/cmh.2023.0173. Epub 2023 May 30.
2
[Clinical study of non-alcoholic fatty liver disease and its combined the chronic HBV infection].非酒精性脂肪性肝病及其合并慢性乙型肝炎病毒感染的临床研究
Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):618-622. doi: 10.3760/cma.j.issn.1007-3418.2017.08.012.
3
Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model.脂肪肝可降低乙型肝炎病毒转基因小鼠模型中乙型肝炎病毒的复制。
J Gastroenterol Hepatol. 2012 Dec;27(12):1858-64. doi: 10.1111/j.1440-1746.2012.07268.x.
4
Impact of non-alcoholic fatty liver disease on chronic hepatitis B.非酒精性脂肪性肝病对慢性乙型肝炎的影响。
Liver Int. 2007 Jun;27(5):607-11. doi: 10.1111/j.1478-3231.2007.01482.x.
5
[Impact of liver steatosis on antiviral effects of pegylated interferon-alpha in patients with chronic hepatitis B].[肝脂肪变性对慢性乙型肝炎患者聚乙二醇化干扰素-α抗病毒疗效的影响]
Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):285-8. doi: 10.3760/cma.j.issn.1007-3418.2012.04.012.
6
Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.肝脂肪变性与恩替卡韦治疗中国慢性乙型肝炎患者失败的关系。
PLoS One. 2012;7(3):e34198. doi: 10.1371/journal.pone.0034198. Epub 2012 Mar 30.
7
[Model building-up and observation on the mouse carried chronic hepatitis B and nonalcoholic fatty liver disease].[慢性乙型肝炎合并非酒精性脂肪性肝病小鼠模型的建立与观察]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Oct;27(5):332-5.
8
Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.非酒精性脂肪性肝病对亚洲慢性乙型肝炎患者结局的影响。
Liver Int. 2022 Aug;42(9):1981-1990. doi: 10.1111/liv.15252. Epub 2022 Jul 7.
9
Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study.肝脂肪变性与乙肝病毒血症之间的负相关关系：一项大型病例对照研究的结果
J Viral Hepat. 2018 Jan;25(1):97-104. doi: 10.1111/jvh.12766. Epub 2017 Aug 25.
10
Chronic hepatitis B and fatty liver: Issues in clinical management.慢性乙型肝炎与脂肪肝：临床管理中的问题。
Clin Res Hepatol Gastroenterol. 2016 Dec;40(6):755-759. doi: 10.1016/j.clinre.2015.12.011. Epub 2016 Feb 2.
引用本文的文献
1
Hepatitis B Virus and microRNAs: A Bioinformatics Approach.乙型肝炎病毒和 microRNAs：一种生物信息学方法。
Int J Mol Sci. 2023 Dec 7;24(24):17224. doi: 10.3390/ijms242417224.
本文引用的文献
1
Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.脂肪性肝病对慢性乙型肝炎长期结局的影响：一项系统评价和个体患者数据荟萃分析的匹配分析。
Clin Mol Hepatol. 2023 Jul;29(3):705-720. doi: 10.3350/cmh.2023.0004. Epub 2023 May 8.
2
Hepatitis B.乙型肝炎
Lancet. 2023 Mar 25;401(10381):1039-1052. doi: 10.1016/S0140-6736(22)01468-4. Epub 2023 Feb 9.
3
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach.采用分层贝叶斯方法预测 2040 年非酒精性脂肪性肝病的全球患病率。
Clin Mol Hepatol. 2022 Oct;28(4):841-850. doi: 10.3350/cmh.2022.0239. Epub 2022 Sep 19.
4
Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis.脂肪变性、乙肝相关肝癌、肝硬化及乙肝表面抗原血清学清除：一项系统评价与荟萃分析
Hepatology. 2023 May 1;77(5):1735-1745. doi: 10.1002/hep.32792. Epub 2023 Apr 17.
5
Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver.慢性病毒性肝炎合并脂肪肝增加肝细胞癌风险和死亡率。
Aliment Pharmacol Ther. 2022 Jan;55(1):97-107. doi: 10.1111/apt.16706. Epub 2021 Nov 24.
6
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.肝脂肪变性和 2 型糖尿病的发展：慢性乙型肝炎和病毒特异性因素的影响。
J Formos Med Assoc. 2022 Aug;121(8):1478-1487. doi: 10.1016/j.jfma.2021.10.014. Epub 2021 Nov 8.
7
Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future.用于研究乙型肝炎病毒病理生物学和免疫的动物模型：过去、现在与未来
Front Microbiol. 2021 Jul 16;12:715450. doi: 10.3389/fmicb.2021.715450. eCollection 2021.
8
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.抗病毒治疗的慢性乙型肝炎患者的受控衰减参数值与肝细胞癌风险。
Hepatol Int. 2021 Aug;15(4):892-900. doi: 10.1007/s12072-021-10205-7. Epub 2021 Jul 14.
9
Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.肝脂肪变性减少与慢性乙型肝炎感染中肝细胞癌的风险增加相关。
Hepatol Int. 2021 Aug;15(4):901-911. doi: 10.1007/s12072-021-10218-2. Epub 2021 Jun 21.
10
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.慢性乙型肝炎中脂肪肝与肝硬化、肝细胞癌和乙型肝炎表面抗原血清学清除的关系。
J Infect Dis. 2021 Jul 15;224(2):294-302. doi: 10.1093/infdis/jiaa739.
Zotero 插件